Topic: 
Cardiovascular Disease and Type 2 Diabetes: Defining the Therapeutic Crossroads 

Objectives: 
• Explore the relationships between T2D, CVD, and CVD risk factors 
• Discuss definitions of primary and secondary prevention of CVD 
• Understand current management for comorbidities of T2D and discuss primary and secondary prevention in type 2 diabetes, including long-term oral anti-platelet trials in secondary prevention 

Speaker: 
Crystal Traylor, MSN, APRN, ANP-C

This webinar is brought to you through a partnership with AstraZeneca.